
Kami Maddocks, MD, The Ohio State University
Advertisement
Articles by Kami Maddocks, MD, The Ohio State University



















Advertisement
Latest Updated Articles
Treating R/R DLBCL With CAR-T: Current BarriersPublished: February 26th 2021 | Updated:
CAR T-Cell Therapy for R/R DLBCLPublished: February 19th 2021 | Updated:
R/R DLBCL: Transplants in the Era of CAR-TPublished: March 12th 2021 | Updated:
R/R DLBCL: Treating With Tafasitamab-LenalidomidePublished: February 12th 2021 | Updated:
Evolving Therapies in R/R DLBCL: Concluding RemarksPublished: March 26th 2021 | Updated:
Bridging Therapy in R/R DLBCLPublished: March 19th 2021 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
FDA Approves Daratumumab and Hyaluronidase Plus VRd for Newly Diagnosed Multiple Myeloma
2
PD-L1 Expression Is More Predictive of Response to Pembrolizumab on Metastatic Sites in High-Grade Serous Ovarian Cancer
3
Dr Braunstein on the FDA Approval of Subcutaneous Daratumumab With VRd For Newly Diagnosed Multiple Myeloma
4
Meta-Analysis Characterizes Nivolumab/Ipilimumab Hyperprogression in Renal Medullary Carcinoma
5

